Variant report
Variant | nsv599089 |
---|---|
Chromosome Location | chr5:98095060-98098285 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000174136 | chromatin interactions |
ENSG00000246763 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4018049 | chr5:98095106-98095107 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs570560102 | chr5:98095130-98095131 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531174953 | chr5:98095131-98095132 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549771078 | chr5:98095132-98095133 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568614998 | chr5:98095139-98095140 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539996156 | chr5:98095194-98095195 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536166097 | chr5:98095197-98095198 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182789518 | chr5:98095215-98095216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs560204743 | chr5:98095233-98095234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566276762 | chr5:98095246-98095247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs371364277 | chr5:98095255-98095256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs111312268 | chr5:98095283-98095284 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs558270369 | chr5:98095314-98095315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs189920069 | chr5:98095342-98095343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs564282014 | chr5:98095385-98095386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs142932552 | chr5:98095409-98095410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532064366 | chr5:98095421-98095422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs371693859 | chr5:98095447-98095448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs555738940 | chr5:98095591-98095592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573990495 | chr5:98095623-98095624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541718260 | chr5:98095624-98095625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551778052 | chr5:98095654-98095655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs527467759 | chr5:98095702-98095703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs545610835 | chr5:98095726-98095727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs114660337 | chr5:98095743-98095744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs375921991 | chr5:98095756-98095757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs568482204 | chr5:98095811-98095812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs531439075 | chr5:98095851-98095852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs72773670 | chr5:98095859-98095860 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs146224074 | chr5:98095947-98095948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs7722260 | chr5:98095961-98095962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548090660 | chr5:98095980-98095981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs566412003 | chr5:98096001-98096002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs182915002 | chr5:98096090-98096091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs372442858 | chr5:98096154-98096155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs906681 | chr5:98096173-98096174 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs570009747 | chr5:98096177-98096178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs537541197 | chr5:98096195-98096196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112524402 | chr5:98096219-98096220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs142410052 | chr5:98096269-98096270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541059255 | chr5:98096301-98096302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376444953 | chr5:98096316-98096317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs553615599 | chr5:98096329-98096330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs369718039 | chr5:98096356-98096357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs545547805 | chr5:98096358-98096359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs564316028 | chr5:98096386-98096387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs187258514 | chr5:98096465-98096466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs150512174 | chr5:98096484-98096485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs116702111 | chr5:98096513-98096514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs373257302 | chr5:98096514-98096515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:98089600-98104000 | Weak transcription | H9 Cell Line | embryonic stem cell |
2 | chr5:98090200-98099000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr5:98095000-98095200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr5:98097200-98097400 | Enhancers | HSMMtube | muscle |
5 | chr5:98097400-98103200 | Weak transcription | HSMMtube | muscle |
6 | chr5:98098200-98101000 | Enhancers | NHDF-Ad | bronchial |